Concepedia

Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases

Steve Fidanze, Scott Erickson, Gary T. Wang, Robert A. Mantei, Richard F. Clark, Bryan K. Sorensen, Nwe Y. BaMaung, Peter Kovar, Eric F. Johnson, Kerren K. Swinger,

Bioorganic & Medicinal Chemistry Letters · 2010 · 56 citations · 9 references

DOIFull text

Open access

Concepts

References

9

Structural basis of inhibitor selectivity in MAP kinases

Zhulun Wang, Bertram Canagarajah, Jeffrey C. Boehm et al. · Structure · 1998 · 425 citations · Full text

, , +16

A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenografts

Liliane Goetsch, Alexandra Gonzalez, Olivier Léger et al. · International Journal of Cancer · 2004 · 217 citations · Full text

, , +14

<i>In vitro</i> biological activity of a novel small-molecule inhibitor of polo-like kinase 1

Timothy J. Lansing, Randy T. McConnell, Derek R. Duckett et al. · Molecular Cancer Therapeutics · 2007 · 139 citations · Full text

, , +16

Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors

Kirk L. Stevens, David Jung, Michael J. Alberti et al. · Organic Letters · 2005 · 87 citations

, , +14

New inhibitors of p38 kinase

Jeffrey C. Boehm, Jerry L. Adams · Expert Opinion on Therapeutic Patents · 2000 · 80 citations

, , +16